DHP Korea Co., Ltd. (131030.KQ) has a MoatMap StockRank of 79/100 based on Quality (64/100), Value (61/100), and Momentum (38/100) factor scores. The current signal is BUY.
OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products.
| Price | $3.73 |
| Market Cap | $59M |
| P/E (TTM) | 7.76 |
| Price/Book | 0.53 |
| Return on Equity | 7.9% |
| Return on Invested Capital | 6.7% |
| Debt/Equity | 0.78 |
| Gross Margin | 55.4% |
| Operating Margin | 12.5% |
| Revenue Growth | 23.8% |
| Free Cash Flow | $-16K |
DHP Korea Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).